FrancophonIA/ELRC3.0 huggingface dataset:
English: For patients with recurrent or progressive glioma, nausea (43 %) and vomiting (36 %) were usually Grade 1 or 2 (0 - 5 episodes of vomiting in 24 hours) and were either self-limiting or readily controlled with standard anti-emetic therapy.
Maltese: Għall-pazjenti bi glijoma rikurrenti jew progressiva, nawsja, (43 %) u rimettar (36 %) ġeneralment kienu ta' Grad 1 jew 2 (0 - 5 episodji ta' rimettar f'24 siegħa) u jew għaddew mingħajr trattament jew ġew ikkontrollati malajr b'terapija antiemetika standard.
English: One was a non-comparative trial in 138 patients (29 % received prior chemotherapy), and the other was a randomised active-controlled trial of TMZ vs procarbazine in a total of 225 patients (67 % received prior treatment with nitrosourea based chemotherapy).
Maltese: Waħda kienet prova mhux komparattiva f'138 pazjent (29 % kienu rċevew il-kemoterapija qabel), u l-oħra kienet prova randomized kontrollata b'mod attiv ta' TMZ vs procarbazine f'total ta' 225 pazjent (67 % kienu rċivew trattament qabel bil-kemoterapija bbażata fuq nitrosourea).
English: Excipients: mannitol (E421), threonine, polysorbate 80, sodium citrate and hydrochloric acid concentrated for pH adjustment.
Maltese: Eċċipjenti: mannitol (E421), threonine, polysorbate 80, sodium citrate u hydrochloric acid konċentrat għall-korrezzjoni tal-pH.
English: and N
Maltese: a:
English: Based on an analysis of population pharmacokinetics in phase II trials, co-administration of dexamethasone, prochlorperazine, phenytoin, carbamazepine, ondansetron, H2 receptor antagonists, or phenobarbital did not alter the clearance of TMZ.
Maltese: II, l-għoti flimkien ta' dexamethasone, prochlorperazine, phenytoin, carbamazepine, ondansetron, antagonisti tar-riċettur ta' l-H2, jew phenobarbital ma biddlux it-tneħħija ta' TMZ.
English: Excipient with known effect: Each hard capsule contains 246 mg of anhydrous lactose.
Maltese: Kull kapsula iebsa fiha 246 mg anhydrous lactose.
English: The resulting solution contains 2.5 mg/ml TMZ.
Maltese: Is-soluzzjoni li tifforma jkun fiha 2.5 mg/ml TMZ.
English: Hemianopia, vision blurred, vision disorder e, visual field defect, diplopia, eye pain
Maltese: Emijanopja, vista mċajpra, disturb fil-vistae, difett filkamp viżiv, diplopja, uġigħ fl-għajn
English: printing ink: shellac, propylene glycol, purified water, ammonium hydroxide, potassium hydroxide, and black iron oxide (E 172).
Maltese: Linka tal-istampar:shellac, propylene glycol, ilma purifikat, ammonium hydroxide, potassium hydroxide, black iron oxide (E 172).
English: Each vial contains 100 mg TMZ.
Maltese: Kull kunjett fih 100 mg TMZ.
English: There may be up to 6 treatment periods (cycles).
Maltese: Jista' jkun hemm sa 6 perijodi ta' kura (ċikli).
English: Temodal 2.5 mg/ml powder for solution for infusion, given as an intravenous infusion over 90 minutes, is bioequivalent to the hard capsule formulation (see section 5.2).
Maltese: Temodal 25 mg/ml trab għal soluzzjoni għall-infużjoni, mogħti bħala infużjoni minn ġol-vina fuq 90 minuta, huwa bioekwivalenti għall-forma ta' kapsula iebsa (ara sezzjoni 5.2).
English: There is limited information in patients over 3 years of age who have taken Temodal.
Maltese: Hemm informazzjoni limitata f'pazjenti li għandhom 'l fuq minn 3 snin li ħadu Temodal.
English: Opportunistic infections (such as Pneumocystis jirovecii pneumonia) and reactivation of infections (such as HBV, CMV) have been observed during the treatment with TMZ (see section 4.8).
Maltese: Ġew osservati infezzjonijiet opportunistiċi (bħal pnewmonja kkawżata minn Pneumocystis jirovecii) u attivazzjoni mill-ġdid ta' infezzjonijiet (bħal HBV, CMV) waqt il-kura b'TMZ (ara sezzjoni 4.8).
English: Temodal 250 mg hard capsules: gelatin, titanium dioxide (E 171), sodium lauril sulfate.
Maltese: Temodal 250 mg kapsuli ibsin: gelatin, titanium dioxide (E 171), sodium lauril sulfate.
English: No data are available on the administration of TMZ in patients with severe hepatic impairment (Child's Class C) or with renal impairment.
Maltese: M'hemmx informazzjoni disponibbli dwar l-għoti ta' TMZ f'pazjenti b'indeboliment epatiku serju (Child's Class C) jew b'indeboliment renali.
English: Gamma-glutamyltransferase increased Injury, poisoning and procedural complications Common:
Maltese: Żieda ta' gamma-glutamyltransferase Korriment, avvelenament u komplikazzjonijiet ta' xi proċedura
English: Endocrine disorders Common:
Maltese: Disturbi fis-sistema endokrinarja
English: Gastrointestinal disorders Very common:
Maltese: Disturbi gastrointestinali
English: This medicine is an antitumour agent.
Maltese: Din il-mediċina hija sustanza kontra t-tumuri.
English: Temodal 2.5 mg/ml powder for solution for infusion temozolomide
Maltese: Temodal 2.5 mg/ml trab għal soluzzjoni għall-infużjoni temozolomide
English: The major route of
Maltese: Waarderweg 39
English: Patients who received concomitant TMZ and RT in a pilot trial for the prolonged 42-day schedule were shown to be at particular risk for developing Pneumocystis jirovecii pneumonia (PCP).
Maltese: Pazjenti li ngħataw TMZ flimkien ma' RT fi prova gwida għall-iskeda mtawla ta' 42 jum intwerew li kellhom riskju partikolari li taqbadhom pulmonite b' Pneumocystis jirovecii (PCP).
English: Powder for solution for infusion.
Maltese: Mhux applikabbli.
English: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Maltese: Pazjenti li għandhom problemi ereditarji rari ta' intolleranza għall-galactose, nuqqas ta' Lapp lactase jew assorbiment ħażin ta' glucose-galactose m'għandhomx jieħdu din il-mediċina.
English: Then, you will have 23 days without Temodal.
Maltese: Imbagħad ikollok 23 jum mingħajr Temodal.
English: In a 400 subject recurrent glioma data set, Grade 4 neutropenia occurred in 8 % of female vs 4 % of male subjects and Grade 4 thrombocytopenia in 8 % of female vs 3 % of male subjects in the first cycle of therapy.
Maltese: F'set ta' dejta għal glijoma b'400 individwu, newtropenija ta' Grad 4 seħħet fi 8 % tan-nisa vs 4 % ta' l-irġiel u tromboċitopenija ta' Grad 4 fi 8 % tan-nisa vs 3 % ta' l-irġiel fl-ewwel ċiklu tat-terapija.
English: Febrile neutropenia, neutropenia, thrombocytopenia, lymphopenia, leukopenia, anaemia
Maltese: Newtropenija bid-deni, newtropenija, tromboċitopenija, limfopenija, lewkopenija, anemija
English: In an open-label, two-way crossover bioequivalence study of the pharmacokinetics of oral and intravenous TMZ in patients with primary CNS malignancies, Temodal 2.5 mg/ml powder for solution for infusion administered over 90 minutes was found to be bioequivalent for Cmax and AUC
Maltese: Fi studju ta' bioekwivalenza two-way crossover, open label dwar il-farmakokinetika ta' TMZ orali u dak li jingħata minn ġol-vina f'pazjenti b'tumuri ewlenin tas-CNS, Temodal 2.5 mg/ml trab għal soluzzjoni għall-infużjoni li ngħata fuq perijodu ta' 90 minuta instab li huwa bioekwivalenti għal Cmax u AUC ta' TMZ u MTIC meta mqabbel ma' Temodal kaspuli ibsin, wara l-għoti ta' doża ta' 150 mg/m2 .
English: Temodal 2.5 mg/ml is supplied as a pack of 1 vial.
Maltese: Temodal 2.5 mg/ml jiġi f'pakkett ta' kunjett wieħed.
English: Each vial must be reconstituted with 41 ml sterilised water for injections.
Maltese: Kull kunjett irid jiġi mħallat b'41 ml ilma għall-injezzjonijiet sterilizzat.
English: Excipient with known effect: Each hard capsule contains 132.8 mg of anhydrous lactose.
Maltese: Kull kapsula iebsa fiha 132.8 mg anhydrous lactose.
English: Sodium citrate (for pH adjustment) Hydrochloric acid concentrated (for pH adjustment)
Maltese: Sodium citrate (għall-korrezzjoni tal-pH)
English: Myelosuppression (neutropenia and thrombocytopenia), which is known dose-limiting toxicity for most cytotoxic agents, including TMZ, was observed.
Maltese: Kienet osservata majelosuppressjoni (newtropenija u tromboċitopenija), li hija magħrufa bħala tossiċità li tillimita d-doża għal ħafna sustanzi ċitotossiċi, inkluż TMZ.
English: Ataxia, balance impaired, cognition impaired, concentration impaired, consciousness decreased, dizziness, hypoesthesia, memory impaired, neurologic disorder, neuropathy d, paraesthesia, somnolence, speech disorder, taste perversion, tremor
Maltese: Atassja, bilanċ indebolit, konjizzjoni indebolita, konċentrazzjoni indebolita, koxjenza mnaqqsa, sturdament, ipoestesija, memorja indebolita, disturb newroloġiku, newropatijad, parestesija, ħedla ta' ngħas. disturb fit-taħdit, taħsir tat-togħma, rogħda
English: Excipient with known effect: Each hard capsule contains 182.2 mg of anhydrous lactose.
Maltese: Kull kapsula iebsa fiha 182.2 mg anhydrous lactose.
English: Most haematologic adverse reactions were reported commonly; the frequency of Grade 3-4 laboratory findings is presented after Table 4.
Maltese: Il-parti l-kbira tar-reazzjonijiet avversi ematoloġiċi ġew rrappurtati b'mod komuni; il-frekwenza ta' sejbiet tal-laboratorju ta' Grad 3-4 hija ppreżentata wara Tabella 4.
English: Temodal 20 mg hard capsules: Each capsule contains 20 mg temozolomide.
Maltese: Temodal 20 mg kapsuli ibsin: Kull kapsula fiha 20 mg temozolamide.
English: Paediatric patients had a higher AUC than adult patients; however, the maximum tolerated dose (MTD) was 1,000 mg/m2 per cycle both in children and in adults.
Maltese: Pazjenti pedjatriċi kellhom AUC ogħla minn dak ta' pazjenti adulti; madankollu, id-doża massima ttollerata (MTD) kienet ta' 1,000 mg/m2 kull ċiklu kemm fit-tfal u kemm fl-adulti.
English: The primary targets of toxicity included the bone marrow, lymphoreticular system, testes, the gastrointestinal tract and, at higher doses, which were lethal to 60 % to 100 % of rats and dogs tested, degeneration of the retina occurred.
Maltese: It-targits primarji tat-tossiċità inkludew il-mudullun, issistema limforetikulari, it-testikoli u l-apparat gastro-intestinali u, f'dożi aktar qawwija, li kkaġunaw il-mewt lil 60 % sa 100 % tal-firien u l-klieb ittestjati, seħħet deġenerazzjoni tar-retina.
English: Adult and paediatric patients 3 years of age or older with recurrent or progressive malignant glioma:
Maltese: Pazjenti adulti u pedjatriċi minn 3 snin 'il fuq bi glijoma malinna rikorrenti jew progressiva:
English: This was followed by monotherapy TMZ (150 - 200 mg/m2) on Days 1 - 5 of every 28-day cycle for up to 6 cycles, starting 4 weeks after the end of RT.
Maltese: Dan kien segwit b'monoterapija ta' TMZ (150 - 200 mg/m2) f'Jiem 1 - 5 ta' kull ċiklu ta' 28 jum sa 6 ċikli, bdew 4 ġimgħat wara li ntemmet r-RT. Pazjenti fil-fergħa tal-kontroll ingħataw RT biss.
English: propylene glycol, purified water, ammonium hydroxide, potassium hydroxide, black iron oxide (E 172).
Maltese: shellac, propylene glycol, ilma purifikat, ammonium hydroxide, potassium hydroxide, u black iron oxide (E172).
English: After reconstitution: 14 hours at 25 C, including infusion time.
Maltese: Wara r-rikostituzzjoni: 14-il siegħa f'temperatura ta' 25ºC, inkluż il-ħin tal-infużjoni.
English: Excipient with known effect: Each hard capsule contains 316.3 mg of anhydrous lactose.
Maltese: Kull kapsula iebsa fiha 316.3 mg anhydrous lactose.
English: Patients with newly-diagnosed glioblastoma multiforme:
Maltese: Pazjenti li jkunu għadhom kif ġew dijanjostikati bi glioblastoma multiforme:
English: Temodal 250 mg hard capsules: Each capsule contains 250 mg temozolomide.
Maltese: Temodal 250 mg kapsuli ibsin: Kull kapsula fiha 250 mg temozolamide.
English: 2220 Heist op den Berg Belgium
Maltese: Heist op den Berg Il-Belġju
English: Temodal 180 mg hard capsules: Each capsule contains 180 mg temozolomide.
Maltese: Temodal 180 mg kapsuli ibsin: Kull kapsula fiha 180 mg temozolamide.
English: Cases of myelodysplastic syndrome and secondary malignancies, including myeloid leukaemia, have also been reported very rarely (see section 4.8).
Maltese: Każijiet ta' sindrome majelodisplastika u tumuri sekondarji, inkluża lewkimja majelojde kienu irrappurtati b'mod rari ħafna (ara sezzjoni 4.8).
English: Hrvatska
Maltese: Qawwa
English: Temodal 5 mg hard capsules: Each capsule contains 5 mg temozolomide.
Maltese: Temodal 5 mg kapsuli ibsin: Kull kapsula fiha 5 mg temozolamide.
English: Frequency groupings are defined according to the following convention: Very common (≥ 1/10); Common
Maltese: Komuni ħafna (≥ 1/10); Komuni (≥ 1/100 sa < 1/10);
English: Deafness f, vertigo, tinnitus, earache
Maltese: Dijarea, stitikezza, nawsja, rimettar
English: In a population pharmacokinetics analysis of clinical trial experience there were 101 female and 169 male subjects for whom nadir neutrophil counts were available and 110 female and 174 male subjects for whom nadir platelet counts were available.
Maltese: F'analiżi bil-farmakokinetiċi ta'popolazzjoni fl-esperjenza bi prova klinika kien hemm 101 mara u 169 raġel li għalihom il-valuri l-aktar baxxi tan-newtrofili kienu disponibbli u 110 mara u 174 raġel li għalihom il-valuri l-aktar baxxi tal-plejtlets kienu disponibbli.
English: Temodal 2.5 mg/ml powder for solution for infusion
Maltese: Temodal 2.5 mg/ml trab għal soluzzjoni għall-infużjoni
English: Based on a population pharmacokinetic analysis in patients 19-78 years of age, clearance of TMZ is not affected by age.
Maltese: Ibbażat fuq analiżi farmakokinetika tal-popolazzjoni f'pazjenti ta' età bejn 19-78 sena, it-tneħħija ta' TMZ mhijiex affettwata mill-età.
English: Excipient with known effect: Each hard capsule contains 154.3 mg of anhydrous lactose.
Maltese: Kull kapsula iebsa fiha 154.3 mg anhydrous lactose.
English: In the noncomparative trial, the PFS at 6 months was 19 %, the median progression-free survival was 2.1 months, and the median overall survival 5.4 months.
Maltese: Fl-istudju mhux komparattiv, il-PFS wara 6 xhur kien ta' 19 %, is-sopravivenza mingħajr progressjoni medjana kienet ta' 2.1. xhur, u l-medjan tas-sopravivenza totali kien ta' 5.4 xhur.
English: < 10 x 10
Maltese: < 10 x 109/l
English: Each hard capsule contains 140 mg temozolomide.
Maltese: Kull kapsula fiha 140 mg temozolamide.
English: Anti-emetic therapy
Maltese: Reazzjoni allerġika
English: The other ingredients are mannitol (E421), threonine, polysorbate 80, sodium citrate (for pH-adjustment) and hydrochloric acid concentrated (for pH-adjustment) (see section 2).
Maltese: Is-sustanzi l-oħra huma mannitol (E421), threonine, polysorbate 80, sodium citrate (għall-korrezzjoni tal-pH) u hydrochloric acid konċentrat (għall-korrezzjoni tal-pH) (ara sezzjoni 2).
English: Each pack contains 1 vial of 100 mg temozolomide.
Maltese: Kull pakkett fih kunjett 1 ta' 100 mg temozolomide.
English: When laboratory abnormalities and adverse events were combined across concomitant and monotherapy treatment phases, Grade 3 or Grade 4 neutrophil abnormalities including neutropenic events were observed in 8 % of the patients.
Maltese: Meta l-anormalitajiet tallaboratorju u l-avvenimenti avversi kienu kkombinati tul il-fażijiet ta' kura konkomitanti u dik bħala monoterapija, kienu osservati anormalitajiet ta' Grad 3 jew ta' Grad 4 fin-newtrofili, inklużi avvenimenti newtropeniċi, fi 8% tal-pazjenti.
English: Temodal 2.5 mg/ml must be administered by intravenous infusion only over a period of 90 minutes.
Maltese: Temodal 2.5 mg/ml għandu jingħata biss permezz ta' infużjoni għal-ġol vina fuq perijodu ta' 90 minuta.
English: Each vial contains 100 mg temozolomide.
Maltese: Kull kunjett fih 100 mg temozolomide.
English: Clinical trial experience with IV
Maltese: Esperjenza tal-prova klinika bl-IV
English: Temodal 5 mg hard capsules temozolomide
Maltese: Temodal 5 mg kapsuli temozolomide
English: Temodal 250 mg hard capsules temozolomide
Maltese: Temodal 250 mg kapsuli temozolomide
English: The reduction in blood cell counts is usually short-lived.
Maltese: It-tnaqqis taċ-ċelluli tad-demm normalment ma jdumx.
English: Nervous system disorders Very common:
Maltese: Disturbi fis-sistema nervuża
English: Plasma clearance, volume of distribution and half-life are independent of dose.
Maltese: It-tneħħija tal-plażma, il-volum tad distribuzzjoni u l-half-life huma indipendenti mid-doża.
English: Temodal 5 mg hard capsules: gelatin, titanium dioxide (E 171), sodium laurilsulfate, yellow iron oxide (E 172), indigo carmine (E 132).
Maltese: Temodal 5 mg kapsuli ibsin: gelatin, titanium dioxide (E 171), sodium lauril sulfate, yellow iron oxide (E 172), indigo carmine (E 132),
English: Then you will have 23 days without Temodal.
Maltese: Imbagħad ser jkollok 23 jum mingħajr Temodal.
English: Temodal 140 mg hard capsules temozolomide
Maltese: Temodal 140 mg kapsuli temozolomide
English: In a multicentre, prospective phase II trial evaluating the safety and efficacy of oral TMZ in the treatment of patients with anaplastic astrocytoma at first relapse, the 6 month PFS was 46 %.
Maltese: II li evalwat is-sigurtà u l-effikaċja ta' TMZ orali fittrattament ta' pazjenti b'astroċitoma anaplastika wara l-ewwel rikaduta, wara 6 xhur il-PFS kienet ta' 46 %.
English: Patients with tumours that have returned or worsened (malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma) receiving Temodal only:
Maltese: Pazjenti b'tumuri li reġgħu ħarġu jew aggravaw (glijoma malinna, bħal glioblastoma multiforme jew astroċitoma anaplastika) li qed jirċievu Temodal biss:
English: Prolonged pancytopenia, aplastic anaemia pancytopenia, petechiae
Maltese: Panċitopenija li tieħu fit-tul, anemija aplastika†, panċitopenija, petekje
English: Temodal 100 mg hard capsules: Each capsule contains 100 mg temozolomide.
Maltese: Temodal 100 mg kapsuli ibsin: Kull kapsula fiha 100 mg temozolamide.
English: Pneumocystis jirovecii pneumonia (PCP) prophylaxis was required during RT and combined TMZ therapy.
Maltese: Terapija biex tilqa għall-pulmonite b'Pneumocystis jirovecii (PCP) kienet meħtieġa waqt it-terapija bl-RT u b'dik ikkombinata ma' TMZ.
English: The body is imprinted with "250 mg", the Schering-Plough logo and two stripes.
Maltese: In-naħa l-oħra hija ttimbrata b'“250 mg”, il-logo ta' Schering-Plough u żewġ strixxi.
English: Temodal 20 mg hard capsules temozolomide
Maltese: Temodal 20 mg kapsuli temozolomide
English:  100 x 10
Maltese: 100 mg
English: Temodal 100 mg hard capsules temozolomide
Maltese: Temodal 100 mg kapsuli temozolomide
English: Temodal 100 mg hard capsules pink
Maltese: Temodal 100 mg kapsuli ibsin roża
English: Hyperglycaemia
Maltese: Kulur tal-qoxra
English: Temodal 180 mg hard capsules temozolomide
Maltese: Temodal 180 mg kapsuli temozolomide
English: Temodal contains a medicine called temozolomide.
Maltese: Temodal fih mediċina msejħa temozolamide.
English: The body is imprinted with "140 mg", the Schering-Plough logo and two stripes.
Maltese: In-naħa l-oħra hija ttimbrata b'“140 mg”, il-logo ta' Schering-Plough u żewġ strixxi.
English: Temodal 140 mg hard capsules blue
Maltese: Temodal 140 mg kapsuli ibsin blu
English: The body is imprinted with "20 mg", the Schering-Plough logo and two stripes.
Maltese: In-naħa l-oħra hija ttimbrata b'“20 mg”, il-logo ta' Schering-Plough u żewġ strixxi.
English: After oral administration to adult patients, TMZ is absorbed rapidly, with peak concentrations reached as early as 20 minutes post-administration (mean time between 0.5 and 1.5 hours).
Maltese: Wara għoti orali lil pazjenti adulti, TMZ jiġi assorbit malajr, bl-ogħla konċentrazzjonijiet jintlaħqu anki 20 minuta wara li jkun ingħata (ħin medju bejn 0.5 u 1.5 sigħat).
English: Temodal 180 mg hard capsules orange
Maltese: Temodal 180 mg kapsuli ibsin oranġjo
English: Temodal 100 mg hard capsules: gelatin, titanium dioxide (E 171), sodium lauril sulfate, red iron oxide (E 172),
Maltese: Temodal 100 mg kapsuli ibsin: gelatin, titanium dioxide (E 171), sodium lauril sulfate, red iron oxide (E 172),
English: This led to hospitalisation and/or discontinuation of TMZ in 8 % and 4 %, respectively.
Maltese: Minħabba f'hekk kellhom jittieħdu l-isptar u/jew kellu jitwaqqaf TMZ f'8 % u 4 %, rispettivament.
English: Common side effects (may affect up to 1 in 10 people) are: - infections, oral infections, wound infections - reduced number of blood cells (neutropenia, lymphopenia, thrombocytopenia) - allergic reaction - increased blood sugar - memory impairment, depression, anxiety, confusion, inability to fall asleep or stay asleep - impaired coordination and balance - difficulty concentrating, change in mental status or alertness, forgetfulness - dizziness, impaired sensations, tingling sensations, shaking, abnormal taste - partial loss of vision, abnormal vision, double vision, dry or painful eyes - deafness, ringing in the ears, earache - blood clot in lung or legs, high blood pressure - pneumonia, shortness of breath, bronchitis, cough, inflammation of your sinuses - stomach or abdominal pain, upset stomach/heartburn, difficulty swallowing - dry skin, itching - muscle damage, muscle weakness, muscle aches and pain - painful joint, back pain - frequent urination, difficulty withholding your urine - fever, flu-like symptoms, pain, feeling unwell, a cold or the flu - fluid retention, swollen legs - liver enzyme elevations - loss of weight, weight gain - radiation injury
Maltese: Effetti sekondarji komuni (jistgħu jaffettwaw sa persuna 1 minn kull 10 ) huma: - infezzjonijiet, infezzjonijiet fil-ħalq, infezzjonijiet f'ferita - numru mnaqqas ta' ċellui tad-demm (newtropenija, limfopenija, tromboċitopenija) - reazzjoni allerġika - żieda fiz-zokkor fid-demm - indeboliment fil-memorja, depressjoni, ansjetà, konfużjoni, ma tkunx tista' torqod jew ma tkunx tista' tibqa' rieqed/rieqda - indeboliment fil-koordinazzjoni u l-bilanċ - diffikultà biex tikkonċentra, bidla fl-istat mentali jew fl-attenzjoni, tinsa' - sturdament, sensazzjonijiet indeboliti, sensazzjonijiet ta' tingiż, rogħda, togħma mhux normali - telf parzjali tal-vista, vista mhux normali, vista doppja, għajnejn xotti jew juġgħu - truxija, żarżir fil-widnejn, uġigħ fil-widna - tagħqid ta' demm fil-pulmun jew fir-riġlejn, pressjoni għolja - pulmonite, qtugħ ta' nifs, bronkite, sogħla, infjammazzjoni fis-sinusis - uġigħ fl-istonku jew fl-addome, stonku mqalleb/ħruq ta' stonku, diffikultà biex tibla' - ġilda xotta, ħakk - ħsara fil-muskoli, dgħufija fil-muskoli, uġigħ u weġgħat fil-muskoli - ġogi juġgħu, uġigħ fid-dahar - tagħmel l-awrina b'mod frekwenti, diffikultà biex iżżomm l-awrina
English: TMZ is an embryotoxic, teratogenic and genotoxic alkylating agent.
Maltese: TMZ huwa aġent alkylating embrijotossiku, teratoġeniku, u ġenotossiku.
English: The body is imprinted with "5 mg", the Schering-Plough logo and two stripes.
Maltese: In-naħa l-oħra hija ttimbrata b'“5 mg”, il-logo ta' Schering-Plough u żewġ strixxi.
English: In patients treated with TMZ in clinical trials, the most common adverse reactions were nausea, vomiting, constipation, anorexia, headache, fatigue, convulsions, and rash.
Maltese: F'pazjenti ttrattati b'TMZ fi provi kliniċi, l-aktar reazzjonijiet avversi komuni kienu nawsja, rimettar, stitikezza, anoreksja, uġigħ ta' ras, għeja, konvulżjonijiet, u raxx.